Get complete Patent Opposition Report for Pohlman

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Pohlman

Explore patent oppositions filed by Pohlman against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3630946Cell Culture MethodsUCB BIOPHARMADec 23, 2024
EP3530670Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKUNov 22, 2024
EP4219687Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyJUNO THERAPEUTICSOct 29, 2024
EP3384049Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 30, 2024
EP3597749Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERApr 26, 2024
EP3911354Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSApr 19, 2024
EP3733847Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATEDMar 1, 2023
EP3464373Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBBJul 26, 2022
EP3498734Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHMEMay 31, 2022
EP3401335Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants ThereofGENENTECHMar 22, 2022